Posts from ‘September, 2010’

VANCOUVER, BRITISH COLUMBIA–(Healthcare Revenue & Marketing Network) - Pyng Clinical Corporation (TSX-V:PYT ) announces the resignation of current President and Chief Executive Officer (CEO), Robert (Bob) Di Silvio, effective September Thirty 2010. Pyng’s Board …
Devices, Personnel
Pyng Clinical, Intraosseous Infusion

TCT 2010 attendees invited to experience the system firsthand NATICK, Mass.–(Healthcare Revenue & Marketing Network)–Corindus Vascular Robotics (www.corindus.com) announced the results of the first medical study of the CorPath® 200 System and invit…
Devices, Interventional Cardiology
Corindus Vascular Robotics, CorPath 200 System

DUBAI, United Arab Emirates, Sept. 20 (HSMN NewsFeed) — NewBridge Pharmaceuticals FZ-LLC of Dubai, UAE announced today that Joseph W. Henein has been appointed President and Chief Executive Officer and a member of the company’s Board of Directors. Mr. H…
Biopharmaceuticals, Venture Capital, Personnel
NewBridge Pharmaceuticals

Asthmatx offers first FDA-approved non-drug procedure for the treatment of severe asthma NATICK, Mass. and SUNNYVALE, Calif., Sept. 20 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE:BSX ) today announced the signing of a definitive merger agre…
Devices, Mergers & Acquisitions
Boston Scientific, Asthmatx, bronchial thermoplasty, Alair , asthma

Enabled Chronix to Complete Proof-of-Concept Studies Confirming Its Serum DNA Biomarkers Can Accurately Detect Early Stage Cancer and to File Two Key Patents Sets Stage for Multiple Commercialization Initiatives Now Underway SAN JOSE, Calif.–(Healt…
Diagnostics, Oncology, Venture Capital
Chronix Biomedical

HAYWARD, Calif.–(Healthcare Sales & Product management Network)–Aradigm Corporation (OTCBB:ARDM ) ("Aradigm") today announced it’s presenting data on September 22, 2010, from its Phase 1 studies at the ERS Annual Congress in Barcelona, Spain. The podiu…
Biopharmaceuticals, Drug Delivery
Aradigm, Ciprofloxacin

SUNNYVALE, Calif.–(Healthcare Revenue & Marketing Network)–Elixir Lab Corporation, a developer of product platforms that combine innovative pharma devices with potent pharmaceuticals for site-specific therapies, announced the initiation of patient enr…
Devices, Interventional Cardiology
Elixir Medical, Novolimus, drug eluting stent, bioabsorbable

WANCHAI, Hong Kong, Sept. 17 (HSMN NewsFeed) — Eddingpharm (Cayman) Inc., a leading specialty laboratory product management company focused on the China market, today announced the closing of a US$24 million Series B financing, co-led by OrbiMed Advisors Cad…
Biopharmaceuticals, Venture Capital
Eddingpharm

FDA approval is based on results from the Company’s landmark MADIT-CRT trial NATICK, Mass., Sept. 16 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE:BSX ) today announced that the U.S. Food and Drug Administration (FDA) has approved an expande…
Devices, Cardiology
Boston Scientific, CRT-D, MADIT-CRT, cardiac resynchronization therapy

Further Medical Study Required for Application to U.S. Food and Drug Administration MINNEAPOLIS–(Healthcare Sales & Marketing Network)–Medtronic, Inc. (NYSE: MDT ) today announced that the company has received CE (Conformité Européenne)…
Devices, Neurology, Regulatory
Medtronic, Deep Brain Stimulation, epilepsy, neuromodulation